Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer

Journal of Computer Assisted Tomography

Volumn 37, Issue 1, 2013, Pages 22-28

  Shan, Xiuhong ^a,b   Wang, Dehang ^a   Chen, Jianhua ^b   Xiao, Xiudi ^b   Jiang, Yanni ^a   Wang, Yafei ^b   Fan, Yu ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

angiogenesis; breast cancer; computed tomography; hypoxia; necrosis

Indexed keywords

BIOMARKERS; CARBONIC ANHYDRASE; CELL ENGINEERING; COMPUTERIZED TOMOGRAPHY; DISEASES; ENDOTHELIAL CELLS; MEDICAL IMAGING; TUMORS;

ANGIOGENESIS; BREAST CANCER; COMPUTED TOMOGRAPHY; CT-VALUE; GLUCOSE TRANSPORTER-1; HYPOXIA; HYPOXIA-INDUCIBLE FACTORS; MICROVESSEL DENSITY; NECROSE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

IMAGE ENHANCEMENT;

CARBONATE DEHYDRATASE IX; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOPLASM; HUMAN; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; MICROVASCULATURE; NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY;

EID: 84872976749     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318279abd1     Document Type: Article

References (31)

1. Bussolati G, Bongiovanni M, Cassoni P, et al. Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: Basis for a new classification. Virchows Arch. 2000;437:360-364.
2. Semenza GL. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell. 2001;107:1-3. (Pubitemid 32972030)
3. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 2000;88:1474-1480. (Pubitemid 30217451)
4. Jiang BH, Semenza GL, Bauer C, et al. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol. 1996;271:C1172-C1180.
5. Grover-Mckay M, Walsh SA, Seftor EA, et al. Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res. 1998;4:115-120. (Pubitemid 28394627)
6. Chung FY, Huang MY, Yeh CS, et al. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer. 2009;9:241.
7. Albertella MR, Loadman PM, Jones PH, et al. Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study. Clin Cancer Res. 2008;14:1096-1104. (Pubitemid 351302556)
8. Wenger RH. Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol. 2000;203:1253-1263. (Pubitemid 30300957)
9. Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60:7075-7083. (Pubitemid 32059187)
10. Blancher C, Harris AL. The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target. Cancer Metastasis Rev. 1998;17:187-194. (Pubitemid 28391953)
11. Opavsky R, Pastorekova S, Zelnik V, et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships. Genomics. 1996;33:480-487. (Pubitemid 26159864)
12. Mizukami Y, Kohgo Y, Chung DC. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin Cancer Res. 2007;13:5670-5674. (Pubitemid 47583891)
13. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 2004;25:581-611. (Pubitemid 39099316)
14. Cuenod CA, Fournier L, Balvay D, et al. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging. 2006;31:188-193.
15. Airley R, Evans A, Mobasheri A, et al. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays. Ann Anat. 2010;192:133-138.
16. Loncaster JA, Harris AL, Davidson SE, et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 2001;61:6394-6399. (Pubitemid 32783244)
17. Cooper R, Sarioglu S, Sokmen S, et al. Glucose transporter-1 (Glut-1): A potential marker of prognosis in rectal carcinoma? Br J Cancer. 2003;89:870-876. (Pubitemid 37175810)
18. Ozcan A, Shen SS, Zhai QJ, et al. Expression of Glut1 in primary renal tumors: morphologic and biologic implications. Am J Clin Pathol. 2007;128:245-254. (Pubitemid 47262622)
19. Chia SK, Wykoff CC, Watson PH, et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 2001;19:3660-3668. (Pubitemid 32786278)
20. Airley RE, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy. 2007;53:233-256. (Pubitemid 47074647)
21. Gatenby RA, Smallbone K, Maini PK, et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer. 2007;97:646-653. (Pubitemid 47339892)
22. Generali D, Fox SB, Berruti A, et al. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer. Endocr Relat Cancer. 2006;13:921-930. (Pubitemid 44763267)
23. Ozbudak IH, Karaveli S, Simsek T, et al. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas. Gynecol Oncol. 2008;108:603-608.
24. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasisVcorrelation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
25. Vaupel P, Schlenger K, Knoop C, et al. Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 1991;51:3316-3322.
26. Vleugel MM, Greijer AE, Shvarts A, et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol. 2005;58:172-177. (Pubitemid 40193803)
27. Tomes L, Emberley E, Niu Y, et al. Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res Treat. 2003;81:61-69. (Pubitemid 37108441)
28. Kim SJ, Rabbani ZN, Dewhirst MW, et al. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer. 2005;49:325-335. (Pubitemid 41139145)
29. Antoch G, Vogt FM, Veit P, et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med. 2005;46:520-525. (Pubitemid 43093165)
30. Shan XH, Hu H, Xiong F, et al. Targeting Glut1-overexpressing MDAYMB-231 cells with 2-deoxy-D-g1ucose modified SPIOs. Eur J Radiol. 2012;81:95-99.
31. Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer. 2002;87:805-812. (Pubitemid 35178760)